Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis

78Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is long known that pyruvate kinase isoform M2 (PKM2) is released into the circulation of cancer patients. ThePKM2levels in patients have been suggested as a diagnostic marker for many types of cancers. However, it is not known howPKM2is released in the blood, and whether the circulating PKM2 has any physiological function(s) in tumor progression. In this report, we demonstrate thatPKM2in the blood facilitates tumor growth by promoting tumor angiogenesis. Our experiments show that PKM2 promotes tumor angiogenesis by increasing endothelial cell proliferation, migration, and cell-ECM adhesion. Only the dimeric PKM2 possess the activity in promoting tumor angiogenesis, which is consistent with the observations that PKM2 in circulation of cancer patients is a dimer form.

Cite

CITATION STYLE

APA

Li, L., Zhang, Y., Qiao, J., Yang, J. J., & Liu, Z. R. (2014). Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. Journal of Biological Chemistry, 289(37), 25812–25821. https://doi.org/10.1074/jbc.M114.576934

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free